Speaker
Kevin John
(Los Alamos National Laboratory)
Description
The current availability of accelerator produced 225Ac from the US Department of Energy Isotope Program’s Tri-Lab (ORNL, BNL, LANL) Research and Production Effort to Provide Accelerator-Produced 225Ac for Radiotherapy will be presented. Additional details will be presented on recent production improvements and ongoing plans for further scaling up our operations. In addition, impacts associated with the radionuclidic quality of the accelerator-produced 225Ac product, concentrating on the 227Ac byproduct, will be provided. Specifics regarding preparations for Current Good Manufacturing Practices (CGMP) level of processing, development of a supporting Drug Master File (DMF) and details of routine material availability will also be discussed.
| Funding Agency | US DOE Isotope Program |
|---|---|
| Email Address | kjohn@lanl.gov |
| Presentation Type | Contributed Oral |
Primary author
Kevin John
(Los Alamos National Laboratory)
